These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 8166712)
1. The amino-terminal half of the cytoplasmic tail of the thyrotropin receptor is essential for full activities of receptor function. Kosugi S; Mori T Biochem Biophys Res Commun; 1994 Apr; 200(1):401-7. PubMed ID: 8166712 [TBL] [Abstract][Full Text] [Related]
2. Cysteine-699, a possible palmitoylation site of the thyrotropin receptor, is not crucial for cAMP or phosphoinositide signaling but is necessary for full surface expression. Kosugi S; Mori T Biochem Biophys Res Commun; 1996 Apr; 221(3):636-40. PubMed ID: 8630013 [TBL] [Abstract][Full Text] [Related]
3. The intracellular region adjacent to plasma membrane (residues 684-692) of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation. Kosugi S; Mori T Biochem Biophys Res Commun; 1994 Mar; 199(3):1497-503. PubMed ID: 8147896 [TBL] [Abstract][Full Text] [Related]
4. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation. Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757 [TBL] [Abstract][Full Text] [Related]
5. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation. Kosugi S; Kohn LD; Akamizu T; Mori T Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349 [TBL] [Abstract][Full Text] [Related]
6. [Signal transduction of the thyrotropin receptor]. Kosugi S; Mori T Nihon Rinsho; 1994 Apr; 52(4):984-9. PubMed ID: 8196191 [TBL] [Abstract][Full Text] [Related]
7. Signal transduction by the human thyrotropin receptor: studies on the role of individual amino acid residues in the carboxyl terminal region of the third cytoplasmic loop. Chazenbalk GD; Nagayama Y; Wadsworth H; Russo D; Rapoport B Mol Endocrinol; 1991 Oct; 5(10):1523-6. PubMed ID: 1663578 [TBL] [Abstract][Full Text] [Related]
8. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD J Biol Chem; 1992 Dec; 267(34):24153-6. PubMed ID: 1332945 [TBL] [Abstract][Full Text] [Related]
9. Constitutive activation of the thyrotropin receptor by mutating CYS-636 in the sixth transmembrane segment. Kosugi S; Mori T Biochem Biophys Res Commun; 1996 May; 222(3):713-7. PubMed ID: 8651910 [TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor. Kosugi S; Shenker A; Mori T FEBS Lett; 1994 Dec; 356(2-3):291-4. PubMed ID: 7805857 [TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Zhang ML; Sugawa H; Kosugi S; Mori T Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086 [TBL] [Abstract][Full Text] [Related]
12. Point mutations of the thyrotropin receptor determining structural requirements for its ability to bind thyrotropin and to stimulate adenylate cyclase activity. Gustavsson B; Westermark B; Heldin NE Biochem Biophys Res Commun; 1994 Mar; 199(2):612-8. PubMed ID: 8135801 [TBL] [Abstract][Full Text] [Related]
13. The first cytoplasmic loop of the thyrotropin receptor is important for phosphoinositide signaling but not for agonist-induced adenylate cyclase activation. Kosugi S; Mori T FEBS Lett; 1994 Mar; 341(2-3):162-6. PubMed ID: 8137933 [TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Parma J; Duprez L; Van Sande J; Cochaux P; Gervy C; Mockel J; Dumont J; Vassart G Nature; 1993 Oct; 365(6447):649-51. PubMed ID: 8413627 [TBL] [Abstract][Full Text] [Related]
15. Identification of amino acid residues in transmembrane helices VI and VII of the lutropin/choriogonadotropin receptor involved in signaling. Fernandez LM; Puett D Biochemistry; 1996 Apr; 35(13):3986-93. PubMed ID: 8672431 [TBL] [Abstract][Full Text] [Related]
16. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist. Frändberg PA; Doufexis M; Kapas S; Chhajlani V Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737 [TBL] [Abstract][Full Text] [Related]
17. Role of the carboxyl-terminal half of the extracellular domain of the human thyrotropin receptor in signal transduction. Nagayama Y; Rapoport B Endocrinology; 1992 Aug; 131(2):548-52. PubMed ID: 1322272 [TBL] [Abstract][Full Text] [Related]
18. [Domain structure and signal transduction mechanisms in the thyrotropin receptor]. Nagayama Y Nihon Rinsho; 1994 Apr; 52(4):979-83. PubMed ID: 8196190 [TBL] [Abstract][Full Text] [Related]
19. The third exoplasmic loop of the thyrotropin receptor is partially involved in signal transduction. Kosugi S; Mori T FEBS Lett; 1994 Jul; 349(1):89-92. PubMed ID: 8045308 [TBL] [Abstract][Full Text] [Related]
20. Identification of specific intracellular domains of the human ETA receptor required for ligand binding and signal transduction. Hashido K; Adachi M; Gamou T; Watanabe T; Furuichi Y; Miyamoto C Cell Mol Biol Res; 1993; 39(1):3-12. PubMed ID: 8287069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]